本页面由Tiger Trade Technology Pte. Ltd.提供服务

CALCIMEDICA

2.24
-0.0870-3.75%
成交量:7.50万
成交额:17.26万
市值:1,526.13万
市盈率:-0.34
高:2.47
开:2.30
低:2.18
收:2.32
52周最高:36.00
52周最低:2.18
股本:682.83万
流通股本:396.30万
量比:0.18
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-6.6528
每股收益(LYR):-9.8500
净资产收益率:-365.70%
总资产收益率:-63.58%
市净率:2.77
市盈率(LYR):-0.23

数据加载中...

公司资料

公司名字:
CALCIMEDICA
交易所:
NASDAQ
成立时间:
- -
员工人数:
16
公司地址:
505 Coast Boulevard South,Suite 307,La Jolla,California,United States
邮编:
92037
电话:
传真:
- -
简介:
CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。公司候选产品作用于钙释放活化钙(“CRAC”)通道,将构成一类新药。

董事

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Eric W. Roberts
Chief Business Officer, Director and Vice Chairman of the Board
Robert N. Wilson
Chairman of the Board
Alan Glicklich
Independent Director
Allan Shaw
Independent Director
Evgeny Zaytsev
Independent Director
Frederic Guerard
Independent Director

股东

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Michael J. Dunn
Chief Operating Officer and President
Stephen Bardin
Chief Financial Officer
Eric W. Roberts
Chief Business Officer, Director and Vice Chairman of the Board
Kenneth A. Stauderman
Chief Scientific Officer
Sudarshan Hebbar
Chief Medical Officer